AU2001231550A1 - Use of mdr-1 inducers for treating or preventing diseases - Google Patents

Use of mdr-1 inducers for treating or preventing diseases

Info

Publication number
AU2001231550A1
AU2001231550A1 AU2001231550A AU3155001A AU2001231550A1 AU 2001231550 A1 AU2001231550 A1 AU 2001231550A1 AU 2001231550 A AU2001231550 A AU 2001231550A AU 3155001 A AU3155001 A AU 3155001A AU 2001231550 A1 AU2001231550 A1 AU 2001231550A1
Authority
AU
Australia
Prior art keywords
mdr
inducers
treating
preventing diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231550A
Inventor
Ulrich Brinkmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Epidauros Biotechnologie AG
Original Assignee
Epidauros Biotechnologie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epidauros Biotechnologie AG filed Critical Epidauros Biotechnologie AG
Publication of AU2001231550A1 publication Critical patent/AU2001231550A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU2001231550A 2000-11-29 2000-11-29 Use of mdr-1 inducers for treating or preventing diseases Abandoned AU2001231550A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2000/011973 WO2002043730A1 (en) 2000-11-29 2000-11-29 Use of mdr-1 inducers for treating or preventing diseases

Publications (1)

Publication Number Publication Date
AU2001231550A1 true AU2001231550A1 (en) 2002-06-11

Family

ID=8164179

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001231550A Abandoned AU2001231550A1 (en) 2000-11-29 2000-11-29 Use of mdr-1 inducers for treating or preventing diseases

Country Status (2)

Country Link
AU (1) AU2001231550A1 (en)
WO (1) WO2002043730A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3635931A1 (en) * 1986-10-22 1988-04-28 Basf Ag ACTIVE SUBSTANCES FOR PREVENTING TUMOR METASAS
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
WO1993008797A1 (en) * 1991-11-01 1993-05-13 New York University Hypericin compositions for treating t-cell mediated diseases
JPH0761937A (en) * 1993-08-26 1995-03-07 Shigeyoshi Kai Anti-inflammatory agent
JP2003510021A (en) * 1999-07-30 2003-03-18 エピダウロス Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications

Also Published As

Publication number Publication date
WO2002043730A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
AU2001249881A1 (en) Method of treating the heart
EP1392292A4 (en) Pyranoindazoles and their use for the treatment of glaucoma
HK1087416A1 (en) Novel immunoadhesins for treating and preventing toxicity and pathogen- mediated diseases
AU2002239491A1 (en) Methods for the treatment of cancer and other diseases and methods of developing the same
AU2001286983A1 (en) Method of treatment
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2001240046A1 (en) Method of treating skin conditions
HUP0200738A3 (en) Method of the treatment of incontinence
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
HUP0302430A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
AU2001253836A1 (en) Method of treating cancer
AU2001289936A1 (en) Use of amino acids for treating pain
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
GB2360453B (en) Treatment of skin conditions
HUP0402298A3 (en) Use of desoxypeganine for treating clinical depression
AU2001262177A1 (en) Method of treatment
AU2001273759A1 (en) Essential oils and chemically related species for the treatment of increased bone resorption
AU2001231550A1 (en) Use of mdr-1 inducers for treating or preventing diseases
AU2001274552A1 (en) Method of fundamentally treating common cold
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease
AU2001253560A1 (en) Methods of treatment
AU2000275033A1 (en) Use of inos inhibitors for treating or preventing myopia
AU2002216996A1 (en) Mixture for treating skin